Shell TechWorks signed a lease for 43,000 square feet of office space in Seaport. The energy innovation hub has outgrown its current Cambridge space and is taking its 90 employees across the river. The Seaport building is still under construction, so the organization likely will move during the second quarter of 2020. [Built In Boston]
Klaviyo announced a new headquarters with five times the space. The email marketing company will move from its current space at 225 Franklin St. to 125 Summer St. The expanded office will make room for 700 new hires in the next two to three years. [Built In Boston]
Life sciences incubator Flagship Pioneering debuted a new startup. Cygnal Therapeutics hit the scene with $65 million in funding to develop two drug candidates. The company’s goal is to disrupt the possible spread of cancer and inflammatory disease through the body’s nervous system by focusing on peripheral nerves. [Press release]
Swedish workforce scheduling platform Quinyx is launching a Boston presence. Initially, the company’s 12 Boston employees will work from a WeWork near South Station. It is hiring in sales, marketing and customer success roles. Quinyx’s platform emphasizes employee satisfaction alongside company profits, its CEO Erik Fjellborg told Boston Business Journal. [Boston Business Journal]
Atlas Venture launched Korro Bio, a biotech startup with a novel approach to gene-editing. Korro will focus on temporarily editing patients’ RNA, rather than permanently editing their DNA. The startup will operate out of Atlas’ Cambridge headquarters. It raised $4 million in June. [Boston Business Journal]
